Literature DB >> 6699149

Isolation of Corynebacterium group JK from clinical specimens with a semiselective medium.

S Wichmann, C H Wirsing von Koenig, E Becker-Boost, H Finger.   

Abstract

A semiselective medium for the detection of multiresistant lipophilic corynebacteria is described. The medium consisted of tryptose agar, supplemented with Tween 80, lecithin, histidine, glycerol, sodium thiosulfate, fosfomycin, ticarcillin, and 5-fluorocytosine. The medium was tentatively called lecithin-Tween medium (LT medium). It promoted mainly the growth of Corynebacterium group JK, which has recently been identified as a cause of serious infection in immunocompromised patients. The application of LT medium to 6,859 routine clinical specimens increased the percentage of Corynebacterium group JK isolation from 0.1 to 1.0%. Although a total of 72 isolates were found in 65 patients, on the basis of clinical criteria only 2 patients were regarded as having an infection with these bacteria. Consequently, Corynebacterium group JK infection can only be diagnosed through a combination of clinical and microbiological findings. In high-risk areas, however, the use of LT medium for surveillance may facilitate the early detection of these potentially dangerous organisms.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6699149      PMCID: PMC271019          DOI: 10.1128/jcm.19.2.204-206.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  Characterization and identification of 95 diphtheroid (group JK) cultures isolated from clinical specimens.

Authors:  P S Riley; D G Hollis; G B Utter; R E Weaver; C N Baker
Journal:  J Clin Microbiol       Date:  1979-03       Impact factor: 5.948

2.  A simple method for the detection of lipolytic activity of micro-organisms and some observations on the influence of the contact between cells and fatty substrates.

Authors:  G SIERRA
Journal:  Antonie Van Leeuwenhoek       Date:  1957       Impact factor: 2.271

3.  [Development of a new quantitative in vitro test for chemical disinfectants (author's transl)].

Authors:  G Reybrouck
Journal:  Zentralbl Bakteriol Orig B       Date:  1977-09

4.  Clinical significance of resistant corynebacteria group JK.

Authors:  H Finger; C H Wirsing von Koenig; S Wichmann; E Becker-Boost; H J Drechsler
Journal:  Lancet       Date:  1983-03-05       Impact factor: 79.321

5.  Use of selective broth enrichment to determine the prevalence of multiply resistant JK corynebacteria on skin.

Authors:  L S Tompkins; F Juffali; W E Stamm
Journal:  J Clin Microbiol       Date:  1982-02       Impact factor: 5.948

6.  Diphtheroid prosthetic valve endocarditis. A study of clinical features and infecting organisms.

Authors:  B E Murray; A W Karchmer; R C Moellering
Journal:  Am J Med       Date:  1980-12       Impact factor: 4.965

7.  [Corynebacteria of the JK group as pathogenic agents].

Authors:  C H Wirsing von König; S Wichmann; H Finger
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1982-12

8.  Sepsis with a new species of Corynebacterium.

Authors:  K R Hande; F G Witebsky; M S Brown; C B Schulman; S E Anderson; A S Levine; J D MacLowery; B A Chabner
Journal:  Ann Intern Med       Date:  1976-10       Impact factor: 25.391

9.  Infection due to Corynebacterium species in marrow transplant patients.

Authors:  W E Stamm; L S Tompkins; K F Wagner; G W Counts; E D Thomas; J D Meyers
Journal:  Ann Intern Med       Date:  1979-08       Impact factor: 25.391

10.  [Septicemia by Corynebacterium group JK in a polytraumatized patient (author's transl)].

Authors:  C H Wirsing von König; H J Drechsler; S Wichmann; H Finger
Journal:  Klin Wochenschr       Date:  1982-03-01
View more
  11 in total

Review 1.  Coryneform bacteria in infectious diseases: clinical and laboratory aspects.

Authors:  M B Coyle; B A Lipsky
Journal:  Clin Microbiol Rev       Date:  1990-07       Impact factor: 26.132

2.  Biochemical and cultural characteristics of "JK" coryneforms.

Authors:  R Bayston; J Higgins
Journal:  J Clin Pathol       Date:  1986-06       Impact factor: 3.411

3.  Rapid identification of group JK and other corynebacteria with the Minitek system.

Authors:  M Slifkin; G M Gil; C Engwall
Journal:  J Clin Microbiol       Date:  1986-08       Impact factor: 5.948

4.  Cutaneous microenvironment of human immunodeficiency virus (HIV)-seropositive and HIV-seronegative individuals, with special reference to Staphylococcus aureus colonization.

Authors:  M Shapiro; K J Smith; W D James; W J Giblin; D J Margolis; A N Foglia; K McGinley; J J Leyden
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

5.  Antimicrobial susceptibility patterns of some recently established coryneform bacteria.

Authors:  G Funke; V Pünter; A von Graevenitz
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

6.  Group JK corynebacteria in skin flora of healthy persons and patients.

Authors:  S Wichmann; C H Wirsing von Koenig; E Becker-Boost; H Finger
Journal:  Eur J Clin Microbiol       Date:  1985-10       Impact factor: 3.267

7.  Rapid method for presumptive identification of Corynebacterium jeikeium.

Authors:  C P Cartwright; F Stock; P M Kruczak-Filipov; V J Gill
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

8.  Antimicrobial susceptibilities of Corynebacterium species and other non-spore-forming gram-positive bacilli to 18 antimicrobial agents.

Authors:  F Soriano; J Zapardiel; E Nieto
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

9.  Urinary tract infection with Corynebacterium urealyticum in South Africa.

Authors:  D Walkden; K P Klugman; S Vally; P Naidoo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-01       Impact factor: 3.267

10.  Use of fosfomycin disks for isolation of diphtheroids.

Authors:  C H Wirsing von Koenig; T Krech; H Finger; M Bergmann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-04       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.